Ann Rheum Dis 78 (8): 1025 - 1032, 2019. doi: 10.1136 / annrheumdis-2019 - 215048 Treatment For preventing attacks, anakinra or canakinumab For symptoms, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and anakinra Anakinra (100 mg subcutaneously once a day) and canakinumab (150 mg subcutaneously every 4 weeks) are proved to prevent attacks (1).